nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—migraine—Prednisone—hematologic cancer	0.457	1	CpDpCtD
Orphenadrine—CYP2B6—Thiotepa—hematologic cancer	0.0314	0.103	CbGbCtD
Orphenadrine—CYP2E1—Thalidomide—hematologic cancer	0.0205	0.0673	CbGbCtD
Orphenadrine—CYP2B6—Ifosfamide—hematologic cancer	0.0178	0.0584	CbGbCtD
Orphenadrine—CYP2E1—Dacarbazine—hematologic cancer	0.0177	0.0579	CbGbCtD
Orphenadrine—CYP2B6—Nilotinib—hematologic cancer	0.0155	0.0507	CbGbCtD
Orphenadrine—CYP2E1—Mitoxantrone—hematologic cancer	0.0137	0.0449	CbGbCtD
Orphenadrine—CYP3A4—Bexarotene—hematologic cancer	0.0116	0.0382	CbGbCtD
Orphenadrine—CYP3A4—Busulfan—hematologic cancer	0.0108	0.0355	CbGbCtD
Orphenadrine—CYP3A4—Lomustine—hematologic cancer	0.0108	0.0355	CbGbCtD
Orphenadrine—CYP2B6—Irinotecan—hematologic cancer	0.0106	0.0349	CbGbCtD
Orphenadrine—CYP3A4—Thiotepa—hematologic cancer	0.00965	0.0316	CbGbCtD
Orphenadrine—CYP2B6—Cisplatin—hematologic cancer	0.00867	0.0284	CbGbCtD
Orphenadrine—CYP2E1—Etoposide—hematologic cancer	0.00864	0.0283	CbGbCtD
Orphenadrine—CYP3A4—Methoxsalen—hematologic cancer	0.00751	0.0246	CbGbCtD
Orphenadrine—CYP3A4—Bortezomib—hematologic cancer	0.00714	0.0234	CbGbCtD
Orphenadrine—CYP2E1—Dexamethasone—hematologic cancer	0.0071	0.0233	CbGbCtD
Orphenadrine—CYP2B6—Dexamethasone—hematologic cancer	0.007	0.023	CbGbCtD
Orphenadrine—CYP3A4—Daunorubicin—hematologic cancer	0.00683	0.0224	CbGbCtD
Orphenadrine—CYP3A4—Cytarabine—hematologic cancer	0.00602	0.0197	CbGbCtD
Orphenadrine—CYP3A4—Teniposide—hematologic cancer	0.00593	0.0195	CbGbCtD
Orphenadrine—CYP2B6—Doxorubicin—hematologic cancer	0.00581	0.0191	CbGbCtD
Orphenadrine—CYP3A4—Ifosfamide—hematologic cancer	0.00548	0.018	CbGbCtD
Orphenadrine—CYP3A4—Imatinib—hematologic cancer	0.00523	0.0171	CbGbCtD
Orphenadrine—CYP3A4—Ruxolitinib—hematologic cancer	0.00493	0.0161	CbGbCtD
Orphenadrine—CYP3A4—Nilotinib—hematologic cancer	0.00475	0.0156	CbGbCtD
Orphenadrine—CYP3A4—Vinorelbine—hematologic cancer	0.00471	0.0155	CbGbCtD
Orphenadrine—CYP3A4—Triamcinolone—hematologic cancer	0.00431	0.0141	CbGbCtD
Orphenadrine—CYP3A4—Dasatinib—hematologic cancer	0.0042	0.0138	CbGbCtD
Orphenadrine—CYP3A4—Mitoxantrone—hematologic cancer	0.00415	0.0136	CbGbCtD
Orphenadrine—CYP3A4—Betamethasone—hematologic cancer	0.0037	0.0121	CbGbCtD
Orphenadrine—CYP3A4—Prednisolone—hematologic cancer	0.00365	0.012	CbGbCtD
Orphenadrine—CYP3A4—Prednisone—hematologic cancer	0.00345	0.0113	CbGbCtD
Orphenadrine—CYP3A4—Irinotecan—hematologic cancer	0.00327	0.0107	CbGbCtD
Orphenadrine—GRIN3B—lung—hematologic cancer	0.00319	0.116	CbGeAlD
Orphenadrine—GRIN3B—testis—hematologic cancer	0.00301	0.11	CbGeAlD
Orphenadrine—CYP3A4—Vinblastine—hematologic cancer	0.0029	0.00952	CbGbCtD
Orphenadrine—CYP3A4—Vincristine—hematologic cancer	0.00286	0.00936	CbGbCtD
Orphenadrine—CYP3A4—Etoposide—hematologic cancer	0.00262	0.00858	CbGbCtD
Orphenadrine—CYP3A4—Dexamethasone—hematologic cancer	0.00215	0.00705	CbGbCtD
Orphenadrine—CYP3A4—Doxorubicin—hematologic cancer	0.00178	0.00585	CbGbCtD
Orphenadrine—GRIN2D—testis—hematologic cancer	0.00134	0.0489	CbGeAlD
Orphenadrine—SCN10A—hematopoietic system—hematologic cancer	0.0013	0.0474	CbGeAlD
Orphenadrine—GRIN3A—testis—hematologic cancer	0.00126	0.046	CbGeAlD
Orphenadrine—SCN9A—lung—hematologic cancer	0.000995	0.0362	CbGeAlD
Orphenadrine—SCN9A—testis—hematologic cancer	0.000938	0.0341	CbGeAlD
Orphenadrine—SCN10A—blood—hematologic cancer	0.000864	0.0314	CbGeAlD
Orphenadrine—SCN1A—lung—hematologic cancer	0.000856	0.0311	CbGeAlD
Orphenadrine—SCN4A—testis—hematologic cancer	0.000837	0.0305	CbGeAlD
Orphenadrine—SCN5A—blood—hematologic cancer	0.000785	0.0286	CbGeAlD
Orphenadrine—SCN10A—lung—hematologic cancer	0.000757	0.0276	CbGeAlD
Orphenadrine—KCNH2—hematopoietic system—hematologic cancer	0.000729	0.0265	CbGeAlD
Orphenadrine—SCN9A—lymph node—hematologic cancer	0.00068	0.0248	CbGeAlD
Orphenadrine—SLC6A2—gonad—hematologic cancer	0.000617	0.0224	CbGeAlD
Orphenadrine—CYP2B6—hematopoietic system—hematologic cancer	0.000598	0.0218	CbGeAlD
Orphenadrine—HRH1—hematopoietic system—hematologic cancer	0.000584	0.0212	CbGeAlD
Orphenadrine—CYP2E1—hematopoietic system—hematologic cancer	0.000561	0.0204	CbGeAlD
Orphenadrine—SCN10A—lymph node—hematologic cancer	0.000518	0.0188	CbGeAlD
Orphenadrine—KCNH2—blood—hematologic cancer	0.000483	0.0176	CbGeAlD
Orphenadrine—SLC6A2—lung—hematologic cancer	0.000471	0.0171	CbGeAlD
Orphenadrine—KCNH2—bone marrow—hematologic cancer	0.000467	0.017	CbGeAlD
Orphenadrine—CYP2B6—gonad—hematologic cancer	0.000455	0.0165	CbGeAlD
Orphenadrine—CYP3A4—hematopoietic system—hematologic cancer	0.000451	0.0164	CbGeAlD
Orphenadrine—SLC6A2—testis—hematologic cancer	0.000445	0.0162	CbGeAlD
Orphenadrine—KCNH2—testis—hematologic cancer	0.000399	0.0145	CbGeAlD
Orphenadrine—CYP2B6—blood—hematologic cancer	0.000396	0.0144	CbGeAlD
Orphenadrine—CYP2E1—blood—hematologic cancer	0.000372	0.0135	CbGeAlD
Orphenadrine—CYP2B6—lung—hematologic cancer	0.000347	0.0126	CbGeAlD
Orphenadrine—HRH1—lung—hematologic cancer	0.000339	0.0123	CbGeAlD
Orphenadrine—CYP2B6—testis—hematologic cancer	0.000328	0.0119	CbGeAlD
Orphenadrine—CYP2E1—lung—hematologic cancer	0.000326	0.0119	CbGeAlD
Orphenadrine—SLC6A2—lymph node—hematologic cancer	0.000322	0.0117	CbGeAlD
Orphenadrine—HRH1—testis—hematologic cancer	0.00032	0.0116	CbGeAlD
Orphenadrine—CYP2E1—testis—hematologic cancer	0.000307	0.0112	CbGeAlD
Orphenadrine—CYP3A4—blood—hematologic cancer	0.000299	0.0109	CbGeAlD
Orphenadrine—KCNH2—lymph node—hematologic cancer	0.000289	0.0105	CbGeAlD
Orphenadrine—HRH1—lymph node—hematologic cancer	0.000232	0.00844	CbGeAlD
Orphenadrine—Toremifene—ESR1—hematologic cancer	0.00016	0.118	CrCbGaD
Orphenadrine—Vision blurred—Prednisolone—hematologic cancer	0.000145	0.0012	CcSEcCtD
Orphenadrine—Somnolence—Alitretinoin—hematologic cancer	0.000145	0.0012	CcSEcCtD
Orphenadrine—Skin disorder—Gemcitabine—hematologic cancer	0.000145	0.0012	CcSEcCtD
Orphenadrine—Nausea—Chlorambucil—hematologic cancer	0.000145	0.0012	CcSEcCtD
Orphenadrine—Somnolence—Ifosfamide—hematologic cancer	0.000144	0.00119	CcSEcCtD
Orphenadrine—Vomiting—Vinblastine—hematologic cancer	0.000142	0.00118	CcSEcCtD
Orphenadrine—Nausea—Nilotinib—hematologic cancer	0.000142	0.00117	CcSEcCtD
Orphenadrine—Feeling abnormal—Thalidomide—hematologic cancer	0.000142	0.00117	CcSEcCtD
Orphenadrine—Chlorphenamine—SLC22A1—hematologic cancer	0.000141	0.104	CrCbGaD
Orphenadrine—Urticaria—Thiotepa—hematologic cancer	0.000141	0.00117	CcSEcCtD
Orphenadrine—Constipation—Carmustine—hematologic cancer	0.000141	0.00117	CcSEcCtD
Orphenadrine—Nausea—Imatinib—hematologic cancer	0.000141	0.00117	CcSEcCtD
Orphenadrine—Hypersensitivity—Bortezomib—hematologic cancer	0.00014	0.00116	CcSEcCtD
Orphenadrine—Headache—Vinblastine—hematologic cancer	0.00014	0.00116	CcSEcCtD
Orphenadrine—Constipation—Alitretinoin—hematologic cancer	0.00014	0.00115	CcSEcCtD
Orphenadrine—Anaphylactic shock—Cisplatin—hematologic cancer	0.000139	0.00115	CcSEcCtD
Orphenadrine—Hypersensitivity—Bleomycin—hematologic cancer	0.000139	0.00115	CcSEcCtD
Orphenadrine—Nausea—Cladribine—hematologic cancer	0.000139	0.00115	CcSEcCtD
Orphenadrine—Constipation—Ifosfamide—hematologic cancer	0.000138	0.00114	CcSEcCtD
Orphenadrine—Hypersensitivity—Vinorelbine—hematologic cancer	0.000137	0.00113	CcSEcCtD
Orphenadrine—Dizziness—Lenalidomide—hematologic cancer	0.000137	0.00113	CcSEcCtD
Orphenadrine—Asthenia—Bortezomib—hematologic cancer	0.000137	0.00113	CcSEcCtD
Orphenadrine—Urticaria—Thalidomide—hematologic cancer	0.000137	0.00113	CcSEcCtD
Orphenadrine—Somnolence—Mitoxantrone—hematologic cancer	0.000136	0.00113	CcSEcCtD
Orphenadrine—Somnolence—Irinotecan—hematologic cancer	0.000136	0.00113	CcSEcCtD
Orphenadrine—Feeling abnormal—Carmustine—hematologic cancer	0.000136	0.00112	CcSEcCtD
Orphenadrine—Tachycardia—Cisplatin—hematologic cancer	0.000136	0.00112	CcSEcCtD
Orphenadrine—Asthenia—Bleomycin—hematologic cancer	0.000136	0.00112	CcSEcCtD
Orphenadrine—Vomiting—Melphalan—hematologic cancer	0.000135	0.00112	CcSEcCtD
Orphenadrine—Skin disorder—Cisplatin—hematologic cancer	0.000135	0.00112	CcSEcCtD
Orphenadrine—Dizziness—Hydroxyurea—hematologic cancer	0.000135	0.00111	CcSEcCtD
Orphenadrine—Pruritus—Bortezomib—hematologic cancer	0.000135	0.00111	CcSEcCtD
Orphenadrine—Feeling abnormal—Alitretinoin—hematologic cancer	0.000135	0.00111	CcSEcCtD
Orphenadrine—Constipation—Vincristine—hematologic cancer	0.000135	0.00111	CcSEcCtD
Orphenadrine—Pruritus—Bleomycin—hematologic cancer	0.000134	0.0011	CcSEcCtD
Orphenadrine—Asthenia—Vinorelbine—hematologic cancer	0.000133	0.0011	CcSEcCtD
Orphenadrine—Feeling abnormal—Ifosfamide—hematologic cancer	0.000133	0.0011	CcSEcCtD
Orphenadrine—Nausea—Vinblastine—hematologic cancer	0.000133	0.0011	CcSEcCtD
Orphenadrine—Somnolence—Gemcitabine—hematologic cancer	0.000133	0.0011	CcSEcCtD
Orphenadrine—Vomiting—Lenalidomide—hematologic cancer	0.000132	0.00109	CcSEcCtD
Orphenadrine—Pruritus—Vinorelbine—hematologic cancer	0.000132	0.00109	CcSEcCtD
Orphenadrine—Constipation—Irinotecan—hematologic cancer	0.000131	0.00108	CcSEcCtD
Orphenadrine—Constipation—Mitoxantrone—hematologic cancer	0.000131	0.00108	CcSEcCtD
Orphenadrine—Hypersensitivity—Thiotepa—hematologic cancer	0.000131	0.00108	CcSEcCtD
Orphenadrine—Urticaria—Alitretinoin—hematologic cancer	0.00013	0.00107	CcSEcCtD
Orphenadrine—Vomiting—Hydroxyurea—hematologic cancer	0.00013	0.00107	CcSEcCtD
Orphenadrine—Headache—Lenalidomide—hematologic cancer	0.00013	0.00107	CcSEcCtD
Orphenadrine—Confusional state—Etoposide—hematologic cancer	0.000129	0.00106	CcSEcCtD
Orphenadrine—Urticaria—Ifosfamide—hematologic cancer	0.000128	0.00106	CcSEcCtD
Orphenadrine—Hallucination—Prednisone—hematologic cancer	0.000128	0.00106	CcSEcCtD
Orphenadrine—Headache—Hydroxyurea—hematologic cancer	0.000128	0.00106	CcSEcCtD
Orphenadrine—Constipation—Gemcitabine—hematologic cancer	0.000128	0.00106	CcSEcCtD
Orphenadrine—Anaphylactic shock—Etoposide—hematologic cancer	0.000128	0.00105	CcSEcCtD
Orphenadrine—Asthenia—Thiotepa—hematologic cancer	0.000127	0.00105	CcSEcCtD
Orphenadrine—Hypersensitivity—Thalidomide—hematologic cancer	0.000127	0.00105	CcSEcCtD
Orphenadrine—Nausea—Melphalan—hematologic cancer	0.000126	0.00104	CcSEcCtD
Orphenadrine—Feeling abnormal—Irinotecan—hematologic cancer	0.000126	0.00104	CcSEcCtD
Orphenadrine—Feeling abnormal—Mitoxantrone—hematologic cancer	0.000126	0.00104	CcSEcCtD
Orphenadrine—Dizziness—Bortezomib—hematologic cancer	0.000126	0.00104	CcSEcCtD
Orphenadrine—Anaphylactic shock—Prednisolone—hematologic cancer	0.000126	0.00104	CcSEcCtD
Orphenadrine—Pruritus—Thiotepa—hematologic cancer	0.000126	0.00104	CcSEcCtD
Orphenadrine—Tachycardia—Etoposide—hematologic cancer	0.000125	0.00103	CcSEcCtD
Orphenadrine—Skin disorder—Etoposide—hematologic cancer	0.000124	0.00102	CcSEcCtD
Orphenadrine—Asthenia—Thalidomide—hematologic cancer	0.000123	0.00102	CcSEcCtD
Orphenadrine—Feeling abnormal—Gemcitabine—hematologic cancer	0.000123	0.00102	CcSEcCtD
Orphenadrine—Dizziness—Vinorelbine—hematologic cancer	0.000123	0.00102	CcSEcCtD
Orphenadrine—Nausea—Lenalidomide—hematologic cancer	0.000123	0.00102	CcSEcCtD
Orphenadrine—Tachycardia—Prednisolone—hematologic cancer	0.000123	0.00101	CcSEcCtD
Orphenadrine—Urticaria—Mitoxantrone—hematologic cancer	0.000122	0.00101	CcSEcCtD
Orphenadrine—Hypersensitivity—Carmustine—hematologic cancer	0.000122	0.001	CcSEcCtD
Orphenadrine—Pruritus—Thalidomide—hematologic cancer	0.000122	0.001	CcSEcCtD
Orphenadrine—Nausea—Hydroxyurea—hematologic cancer	0.000121	0.001	CcSEcCtD
Orphenadrine—Vomiting—Bortezomib—hematologic cancer	0.000121	0.001	CcSEcCtD
Orphenadrine—Hypersensitivity—Alitretinoin—hematologic cancer	0.00012	0.000995	CcSEcCtD
Orphenadrine—Vomiting—Bleomycin—hematologic cancer	0.00012	0.000993	CcSEcCtD
Orphenadrine—Drowsiness—Methotrexate—hematologic cancer	0.00012	0.00099	CcSEcCtD
Orphenadrine—Headache—Bortezomib—hematologic cancer	0.000119	0.000986	CcSEcCtD
Orphenadrine—Hypersensitivity—Ifosfamide—hematologic cancer	0.000119	0.000983	CcSEcCtD
Orphenadrine—Asthenia—Carmustine—hematologic cancer	0.000118	0.000978	CcSEcCtD
Orphenadrine—Vomiting—Vinorelbine—hematologic cancer	0.000118	0.000977	CcSEcCtD
Orphenadrine—Dizziness—Thiotepa—hematologic cancer	0.000117	0.00097	CcSEcCtD
Orphenadrine—Asthenia—Alitretinoin—hematologic cancer	0.000117	0.000969	CcSEcCtD
Orphenadrine—Headache—Vinorelbine—hematologic cancer	0.000117	0.000962	CcSEcCtD
Orphenadrine—Hypersensitivity—Vincristine—hematologic cancer	0.000116	0.000959	CcSEcCtD
Orphenadrine—Asthenia—Ifosfamide—hematologic cancer	0.000116	0.000957	CcSEcCtD
Orphenadrine—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000116	0.000956	CcSEcCtD
Orphenadrine—Pruritus—Alitretinoin—hematologic cancer	0.000116	0.000955	CcSEcCtD
Orphenadrine—Feeling abnormal—Cisplatin—hematologic cancer	0.000115	0.000948	CcSEcCtD
Orphenadrine—Phenoxybenzamine—SLC22A1—hematologic cancer	0.000114	0.0845	CrCbGaD
Orphenadrine—Pruritus—Ifosfamide—hematologic cancer	0.000114	0.000944	CcSEcCtD
Orphenadrine—Dizziness—Thalidomide—hematologic cancer	0.000114	0.000938	CcSEcCtD
Orphenadrine—Somnolence—Etoposide—hematologic cancer	0.000113	0.000937	CcSEcCtD
Orphenadrine—Nausea—Bortezomib—hematologic cancer	0.000113	0.000935	CcSEcCtD
Orphenadrine—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000113	0.000934	CcSEcCtD
Orphenadrine—Hypersensitivity—Irinotecan—hematologic cancer	0.000113	0.000934	CcSEcCtD
Orphenadrine—Asthenia—Vincristine—hematologic cancer	0.000113	0.000933	CcSEcCtD
Orphenadrine—Tachycardia—Triamcinolone—hematologic cancer	0.000113	0.000933	CcSEcCtD
Orphenadrine—Vomiting—Thiotepa—hematologic cancer	0.000113	0.000933	CcSEcCtD
Orphenadrine—Nausea—Bleomycin—hematologic cancer	0.000112	0.000927	CcSEcCtD
Orphenadrine—Drowsiness—Epirubicin—hematologic cancer	0.000112	0.000926	CcSEcCtD
Orphenadrine—Headache—Thiotepa—hematologic cancer	0.000111	0.000919	CcSEcCtD
Orphenadrine—Nausea—Vinorelbine—hematologic cancer	0.00011	0.000913	CcSEcCtD
Orphenadrine—Asthenia—Irinotecan—hematologic cancer	0.00011	0.000909	CcSEcCtD
Orphenadrine—Asthenia—Mitoxantrone—hematologic cancer	0.00011	0.000909	CcSEcCtD
Orphenadrine—Vomiting—Thalidomide—hematologic cancer	0.000109	0.000902	CcSEcCtD
Orphenadrine—Dizziness—Carmustine—hematologic cancer	0.000109	0.000901	CcSEcCtD
Orphenadrine—Constipation—Etoposide—hematologic cancer	0.000109	0.000901	CcSEcCtD
Orphenadrine—Dizziness—Alitretinoin—hematologic cancer	0.000108	0.000893	CcSEcCtD
Orphenadrine—Headache—Thalidomide—hematologic cancer	0.000108	0.000889	CcSEcCtD
Orphenadrine—Asthenia—Gemcitabine—hematologic cancer	0.000107	0.000886	CcSEcCtD
Orphenadrine—Dizziness—Ifosfamide—hematologic cancer	0.000107	0.000882	CcSEcCtD
Orphenadrine—Pruritus—Gemcitabine—hematologic cancer	0.000106	0.000873	CcSEcCtD
Orphenadrine—Vision blurred—Prednisone—hematologic cancer	0.000106	0.000872	CcSEcCtD
Orphenadrine—Nausea—Thiotepa—hematologic cancer	0.000106	0.000872	CcSEcCtD
Orphenadrine—Feeling abnormal—Etoposide—hematologic cancer	0.000105	0.000869	CcSEcCtD
Orphenadrine—Anaphylactic shock—Betamethasone—hematologic cancer	0.000105	0.000867	CcSEcCtD
Orphenadrine—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000105	0.000867	CcSEcCtD
Orphenadrine—Vomiting—Carmustine—hematologic cancer	0.000105	0.000867	CcSEcCtD
Orphenadrine—Dizziness—Vincristine—hematologic cancer	0.000104	0.00086	CcSEcCtD
Orphenadrine—Vomiting—Alitretinoin—hematologic cancer	0.000104	0.000858	CcSEcCtD
Orphenadrine—Drowsiness—Doxorubicin—hematologic cancer	0.000104	0.000857	CcSEcCtD
Orphenadrine—Feeling abnormal—Prednisolone—hematologic cancer	0.000104	0.000857	CcSEcCtD
Orphenadrine—Headache—Carmustine—hematologic cancer	0.000103	0.000854	CcSEcCtD
Orphenadrine—Agitation—Prednisone—hematologic cancer	0.000103	0.000851	CcSEcCtD
Orphenadrine—Vomiting—Ifosfamide—hematologic cancer	0.000103	0.000848	CcSEcCtD
Orphenadrine—Hypersensitivity—Cisplatin—hematologic cancer	0.000103	0.000848	CcSEcCtD
Orphenadrine—Tachycardia—Betamethasone—hematologic cancer	0.000103	0.000847	CcSEcCtD
Orphenadrine—Tachycardia—Dexamethasone—hematologic cancer	0.000103	0.000847	CcSEcCtD
Orphenadrine—Headache—Alitretinoin—hematologic cancer	0.000102	0.000846	CcSEcCtD
Orphenadrine—Nausea—Thalidomide—hematologic cancer	0.000102	0.000843	CcSEcCtD
Orphenadrine—Dizziness—Irinotecan—hematologic cancer	0.000101	0.000838	CcSEcCtD
Orphenadrine—Urticaria—Etoposide—hematologic cancer	0.000101	0.000837	CcSEcCtD
Orphenadrine—Vomiting—Vincristine—hematologic cancer	0.0001	0.000827	CcSEcCtD
Orphenadrine—Urticaria—Prednisolone—hematologic cancer	0.0001	0.000826	CcSEcCtD
Orphenadrine—Asthenia—Cisplatin—hematologic cancer	9.99e-05	0.000825	CcSEcCtD
Orphenadrine—Headache—Vincristine—hematologic cancer	9.87e-05	0.000815	CcSEcCtD
Orphenadrine—Nausea—Carmustine—hematologic cancer	9.8e-05	0.00081	CcSEcCtD
Orphenadrine—Vomiting—Mitoxantrone—hematologic cancer	9.75e-05	0.000806	CcSEcCtD
Orphenadrine—Vomiting—Irinotecan—hematologic cancer	9.75e-05	0.000806	CcSEcCtD
Orphenadrine—Nausea—Alitretinoin—hematologic cancer	9.71e-05	0.000802	CcSEcCtD
Orphenadrine—Headache—Mitoxantrone—hematologic cancer	9.61e-05	0.000794	CcSEcCtD
Orphenadrine—Headache—Irinotecan—hematologic cancer	9.61e-05	0.000794	CcSEcCtD
Orphenadrine—Nausea—Ifosfamide—hematologic cancer	9.6e-05	0.000793	CcSEcCtD
Orphenadrine—Diphenhydramine—SLC22A1—hematologic cancer	9.59e-05	0.0708	CrCbGaD
Orphenadrine—Feeling abnormal—Triamcinolone—hematologic cancer	9.54e-05	0.000788	CcSEcCtD
Orphenadrine—Vomiting—Gemcitabine—hematologic cancer	9.5e-05	0.000785	CcSEcCtD
Orphenadrine—Hypersensitivity—Etoposide—hematologic cancer	9.4e-05	0.000777	CcSEcCtD
Orphenadrine—Headache—Gemcitabine—hematologic cancer	9.36e-05	0.000773	CcSEcCtD
Orphenadrine—Nausea—Vincristine—hematologic cancer	9.36e-05	0.000773	CcSEcCtD
Orphenadrine—Hypersensitivity—Prednisolone—hematologic cancer	9.27e-05	0.000766	CcSEcCtD
Orphenadrine—Urticaria—Triamcinolone—hematologic cancer	9.2e-05	0.000759	CcSEcCtD
Orphenadrine—Asthenia—Etoposide—hematologic cancer	9.16e-05	0.000756	CcSEcCtD
Orphenadrine—Anaphylactic shock—Prednisone—hematologic cancer	9.15e-05	0.000755	CcSEcCtD
Orphenadrine—Nausea—Irinotecan—hematologic cancer	9.11e-05	0.000753	CcSEcCtD
Orphenadrine—Nausea—Mitoxantrone—hematologic cancer	9.11e-05	0.000753	CcSEcCtD
Orphenadrine—Pruritus—Etoposide—hematologic cancer	9.03e-05	0.000746	CcSEcCtD
Orphenadrine—Tachycardia—Prednisone—hematologic cancer	8.93e-05	0.000737	CcSEcCtD
Orphenadrine—Skin disorder—Prednisone—hematologic cancer	8.88e-05	0.000734	CcSEcCtD
Orphenadrine—Nausea—Gemcitabine—hematologic cancer	8.88e-05	0.000733	CcSEcCtD
Orphenadrine—Vomiting—Cisplatin—hematologic cancer	8.86e-05	0.000731	CcSEcCtD
Orphenadrine—Vision blurred—Methotrexate—hematologic cancer	8.83e-05	0.000729	CcSEcCtD
Orphenadrine—Feeling abnormal—Betamethasone—hematologic cancer	8.65e-05	0.000715	CcSEcCtD
Orphenadrine—Feeling abnormal—Dexamethasone—hematologic cancer	8.65e-05	0.000715	CcSEcCtD
Orphenadrine—Tension—Epirubicin—hematologic cancer	8.6e-05	0.00071	CcSEcCtD
Orphenadrine—Reboxetine—ABCB1—hematologic cancer	8.57e-05	0.0633	CrCbGaD
Orphenadrine—Hypersensitivity—Triamcinolone—hematologic cancer	8.53e-05	0.000704	CcSEcCtD
Orphenadrine—Dizziness—Etoposide—hematologic cancer	8.44e-05	0.000697	CcSEcCtD
Orphenadrine—Urticaria—Dexamethasone—hematologic cancer	8.34e-05	0.000689	CcSEcCtD
Orphenadrine—Urticaria—Betamethasone—hematologic cancer	8.34e-05	0.000689	CcSEcCtD
Orphenadrine—Dizziness—Prednisolone—hematologic cancer	8.32e-05	0.000687	CcSEcCtD
Orphenadrine—Asthenia—Triamcinolone—hematologic cancer	8.3e-05	0.000686	CcSEcCtD
Orphenadrine—Nausea—Cisplatin—hematologic cancer	8.27e-05	0.000683	CcSEcCtD
Orphenadrine—Vision blurred—Epirubicin—hematologic cancer	8.26e-05	0.000682	CcSEcCtD
Orphenadrine—Pruritus—Triamcinolone—hematologic cancer	8.19e-05	0.000676	CcSEcCtD
Orphenadrine—Vomiting—Etoposide—hematologic cancer	8.11e-05	0.00067	CcSEcCtD
Orphenadrine—Agitation—Epirubicin—hematologic cancer	8.05e-05	0.000665	CcSEcCtD
Orphenadrine—Headache—Etoposide—hematologic cancer	7.99e-05	0.00066	CcSEcCtD
Orphenadrine—Tension—Doxorubicin—hematologic cancer	7.96e-05	0.000657	CcSEcCtD
Orphenadrine—Headache—Prednisolone—hematologic cancer	7.89e-05	0.000651	CcSEcCtD
Orphenadrine—Constipation—Prednisone—hematologic cancer	7.82e-05	0.000646	CcSEcCtD
Orphenadrine—Palpitations—Epirubicin—hematologic cancer	7.75e-05	0.00064	CcSEcCtD
Orphenadrine—Confusional state—Methotrexate—hematologic cancer	7.71e-05	0.000637	CcSEcCtD
Orphenadrine—Dizziness—Triamcinolone—hematologic cancer	7.65e-05	0.000632	CcSEcCtD
Orphenadrine—Anaphylactic shock—Methotrexate—hematologic cancer	7.64e-05	0.000631	CcSEcCtD
Orphenadrine—Vision blurred—Doxorubicin—hematologic cancer	7.64e-05	0.000631	CcSEcCtD
Orphenadrine—Nausea—Etoposide—hematologic cancer	7.58e-05	0.000626	CcSEcCtD
Orphenadrine—Feeling abnormal—Prednisone—hematologic cancer	7.54e-05	0.000622	CcSEcCtD
Orphenadrine—Asthenia—Dexamethasone—hematologic cancer	7.54e-05	0.000622	CcSEcCtD
Orphenadrine—Asthenia—Betamethasone—hematologic cancer	7.54e-05	0.000622	CcSEcCtD
Orphenadrine—Nausea—Prednisolone—hematologic cancer	7.48e-05	0.000617	CcSEcCtD
Orphenadrine—Agitation—Doxorubicin—hematologic cancer	7.45e-05	0.000616	CcSEcCtD
Orphenadrine—Pruritus—Dexamethasone—hematologic cancer	7.43e-05	0.000614	CcSEcCtD
Orphenadrine—Pruritus—Betamethasone—hematologic cancer	7.43e-05	0.000614	CcSEcCtD
Orphenadrine—Skin disorder—Methotrexate—hematologic cancer	7.42e-05	0.000613	CcSEcCtD
Orphenadrine—Vomiting—Triamcinolone—hematologic cancer	7.36e-05	0.000608	CcSEcCtD
Orphenadrine—Urticaria—Prednisone—hematologic cancer	7.27e-05	0.0006	CcSEcCtD
Orphenadrine—Headache—Triamcinolone—hematologic cancer	7.25e-05	0.000599	CcSEcCtD
Orphenadrine—Imipramine—SLC22A1—hematologic cancer	7.24e-05	0.0535	CrCbGaD
Orphenadrine—Confusional state—Epirubicin—hematologic cancer	7.21e-05	0.000596	CcSEcCtD
Orphenadrine—Palpitations—Doxorubicin—hematologic cancer	7.17e-05	0.000592	CcSEcCtD
Orphenadrine—Anaphylactic shock—Epirubicin—hematologic cancer	7.15e-05	0.000591	CcSEcCtD
Orphenadrine—Tachycardia—Epirubicin—hematologic cancer	6.98e-05	0.000577	CcSEcCtD
Orphenadrine—Skin disorder—Epirubicin—hematologic cancer	6.95e-05	0.000574	CcSEcCtD
Orphenadrine—Dizziness—Betamethasone—hematologic cancer	6.95e-05	0.000574	CcSEcCtD
Orphenadrine—Dizziness—Dexamethasone—hematologic cancer	6.95e-05	0.000574	CcSEcCtD
Orphenadrine—Nausea—Triamcinolone—hematologic cancer	6.88e-05	0.000568	CcSEcCtD
Orphenadrine—Somnolence—Methotrexate—hematologic cancer	6.8e-05	0.000561	CcSEcCtD
Orphenadrine—Toremifene—ABCB1—hematologic cancer	6.79e-05	0.0502	CrCbGaD
Orphenadrine—Hypersensitivity—Prednisone—hematologic cancer	6.74e-05	0.000557	CcSEcCtD
Orphenadrine—Fenoprofen—ALB—hematologic cancer	6.71e-05	0.0496	CrCbGaD
Orphenadrine—Vomiting—Betamethasone—hematologic cancer	6.68e-05	0.000552	CcSEcCtD
Orphenadrine—Vomiting—Dexamethasone—hematologic cancer	6.68e-05	0.000552	CcSEcCtD
Orphenadrine—Confusional state—Doxorubicin—hematologic cancer	6.67e-05	0.000551	CcSEcCtD
Orphenadrine—Anaphylactic shock—Doxorubicin—hematologic cancer	6.62e-05	0.000547	CcSEcCtD
Orphenadrine—Headache—Betamethasone—hematologic cancer	6.58e-05	0.000543	CcSEcCtD
Orphenadrine—Headache—Dexamethasone—hematologic cancer	6.58e-05	0.000543	CcSEcCtD
Orphenadrine—Asthenia—Prednisone—hematologic cancer	6.56e-05	0.000542	CcSEcCtD
Orphenadrine—Tamoxifen—ABCG2—hematologic cancer	6.52e-05	0.0482	CrCbGaD
Orphenadrine—Pruritus—Prednisone—hematologic cancer	6.47e-05	0.000534	CcSEcCtD
Orphenadrine—Tachycardia—Doxorubicin—hematologic cancer	6.46e-05	0.000534	CcSEcCtD
Orphenadrine—Skin disorder—Doxorubicin—hematologic cancer	6.43e-05	0.000531	CcSEcCtD
Orphenadrine—Tamoxifen—ESR1—hematologic cancer	6.39e-05	0.0472	CrCbGaD
Orphenadrine—Somnolence—Epirubicin—hematologic cancer	6.36e-05	0.000525	CcSEcCtD
Orphenadrine—Feeling abnormal—Methotrexate—hematologic cancer	6.3e-05	0.00052	CcSEcCtD
Orphenadrine—Nausea—Betamethasone—hematologic cancer	6.24e-05	0.000515	CcSEcCtD
Orphenadrine—Nausea—Dexamethasone—hematologic cancer	6.24e-05	0.000515	CcSEcCtD
Orphenadrine—Constipation—Epirubicin—hematologic cancer	6.12e-05	0.000505	CcSEcCtD
Orphenadrine—Urticaria—Methotrexate—hematologic cancer	6.07e-05	0.000502	CcSEcCtD
Orphenadrine—Dizziness—Prednisone—hematologic cancer	6.05e-05	0.0005	CcSEcCtD
Orphenadrine—Feeling abnormal—Epirubicin—hematologic cancer	5.89e-05	0.000487	CcSEcCtD
Orphenadrine—Somnolence—Doxorubicin—hematologic cancer	5.88e-05	0.000486	CcSEcCtD
Orphenadrine—Vomiting—Prednisone—hematologic cancer	5.82e-05	0.00048	CcSEcCtD
Orphenadrine—Phenprocoumon—ALB—hematologic cancer	5.79e-05	0.0428	CrCbGaD
Orphenadrine—Headache—Prednisone—hematologic cancer	5.73e-05	0.000473	CcSEcCtD
Orphenadrine—Urticaria—Epirubicin—hematologic cancer	5.68e-05	0.000469	CcSEcCtD
Orphenadrine—Constipation—Doxorubicin—hematologic cancer	5.66e-05	0.000467	CcSEcCtD
Orphenadrine—Hypersensitivity—Methotrexate—hematologic cancer	5.63e-05	0.000465	CcSEcCtD
Orphenadrine—Fluoxetine—ALB—hematologic cancer	5.63e-05	0.0416	CrCbGaD
Orphenadrine—Asthenia—Methotrexate—hematologic cancer	5.48e-05	0.000453	CcSEcCtD
Orphenadrine—Feeling abnormal—Doxorubicin—hematologic cancer	5.45e-05	0.00045	CcSEcCtD
Orphenadrine—Nausea—Prednisone—hematologic cancer	5.43e-05	0.000449	CcSEcCtD
Orphenadrine—Pruritus—Methotrexate—hematologic cancer	5.41e-05	0.000447	CcSEcCtD
Orphenadrine—Fluoxetine—ABCB1—hematologic cancer	5.37e-05	0.0397	CrCbGaD
Orphenadrine—Hypersensitivity—Epirubicin—hematologic cancer	5.27e-05	0.000435	CcSEcCtD
Orphenadrine—Urticaria—Doxorubicin—hematologic cancer	5.26e-05	0.000434	CcSEcCtD
Orphenadrine—Asthenia—Epirubicin—hematologic cancer	5.13e-05	0.000424	CcSEcCtD
Orphenadrine—Warfarin—ALB—hematologic cancer	5.13e-05	0.0379	CrCbGaD
Orphenadrine—Pruritus—Epirubicin—hematologic cancer	5.06e-05	0.000418	CcSEcCtD
Orphenadrine—Dizziness—Methotrexate—hematologic cancer	5.05e-05	0.000417	CcSEcCtD
Orphenadrine—Hypersensitivity—Doxorubicin—hematologic cancer	4.88e-05	0.000403	CcSEcCtD
Orphenadrine—Vomiting—Methotrexate—hematologic cancer	4.86e-05	0.000401	CcSEcCtD
Orphenadrine—Headache—Methotrexate—hematologic cancer	4.79e-05	0.000395	CcSEcCtD
Orphenadrine—Asthenia—Doxorubicin—hematologic cancer	4.75e-05	0.000392	CcSEcCtD
Orphenadrine—Dizziness—Epirubicin—hematologic cancer	4.73e-05	0.000391	CcSEcCtD
Orphenadrine—Pruritus—Doxorubicin—hematologic cancer	4.68e-05	0.000387	CcSEcCtD
Orphenadrine—Vomiting—Epirubicin—hematologic cancer	4.55e-05	0.000376	CcSEcCtD
Orphenadrine—Nausea—Methotrexate—hematologic cancer	4.54e-05	0.000375	CcSEcCtD
Orphenadrine—Headache—Epirubicin—hematologic cancer	4.48e-05	0.00037	CcSEcCtD
Orphenadrine—Dizziness—Doxorubicin—hematologic cancer	4.38e-05	0.000361	CcSEcCtD
Orphenadrine—Nausea—Epirubicin—hematologic cancer	4.25e-05	0.000351	CcSEcCtD
Orphenadrine—Vomiting—Doxorubicin—hematologic cancer	4.21e-05	0.000348	CcSEcCtD
Orphenadrine—Headache—Doxorubicin—hematologic cancer	4.15e-05	0.000342	CcSEcCtD
Orphenadrine—Nausea—Doxorubicin—hematologic cancer	3.93e-05	0.000325	CcSEcCtD
Orphenadrine—Trimipramine—ABCB1—hematologic cancer	2.84e-05	0.021	CrCbGaD
Orphenadrine—Promethazine—ABCB1—hematologic cancer	2.73e-05	0.0202	CrCbGaD
Orphenadrine—Tamoxifen—ABCB1—hematologic cancer	2.71e-05	0.0201	CrCbGaD
Orphenadrine—Doxepin—ABCB1—hematologic cancer	2.71e-05	0.02	CrCbGaD
Orphenadrine—Methadone—ABCB1—hematologic cancer	2.69e-05	0.0199	CrCbGaD
Orphenadrine—Amitriptyline—ALB—hematologic cancer	2.19e-05	0.0162	CrCbGaD
Orphenadrine—Imipramine—ABCB1—hematologic cancer	2.1e-05	0.0156	CrCbGaD
Orphenadrine—Amitriptyline—ABCB1—hematologic cancer	2.09e-05	0.0155	CrCbGaD
Orphenadrine—CYP3A4—Metabolism—FHL2—hematologic cancer	4.27e-06	4.87e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—STAT1—hematologic cancer	4.25e-06	4.84e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CREB1—hematologic cancer	4.23e-06	4.82e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CCL2—hematologic cancer	4.2e-06	4.79e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL6R—hematologic cancer	4.19e-06	4.77e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AGRN—hematologic cancer	4.19e-06	4.77e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—STAT1—hematologic cancer	4.18e-06	4.76e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CCL2—hematologic cancer	4.14e-06	4.71e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3R1—hematologic cancer	4.13e-06	4.7e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL6R—hematologic cancer	4.12e-06	4.7e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3R1—hematologic cancer	4.06e-06	4.62e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—JAK2—hematologic cancer	4.01e-06	4.57e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTP1—hematologic cancer	3.99e-06	4.55e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—MAP2K1—hematologic cancer	3.99e-06	4.55e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GRB2—hematologic cancer	3.97e-06	4.53e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HMMR—hematologic cancer	3.97e-06	4.52e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—IDH2—hematologic cancer	3.97e-06	4.52e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CD—hematologic cancer	3.97e-06	4.52e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PDGFA—hematologic cancer	3.96e-06	4.52e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—JAK2—hematologic cancer	3.95e-06	4.49e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—MAP2K1—hematologic cancer	3.93e-06	4.48e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTP1—hematologic cancer	3.91e-06	4.46e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GRB2—hematologic cancer	3.91e-06	4.45e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KITLG—hematologic cancer	3.91e-06	4.45e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CD—hematologic cancer	3.9e-06	4.45e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PDGFA—hematologic cancer	3.9e-06	4.44e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KITLG—hematologic cancer	3.84e-06	4.38e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—STAT5A—hematologic cancer	3.82e-06	4.35e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3CB—hematologic cancer	3.81e-06	4.34e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CDKN2B—hematologic cancer	3.79e-06	4.31e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ABCB1—hematologic cancer	3.78e-06	4.31e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—STAT5A—hematologic cancer	3.76e-06	4.28e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3CB—hematologic cancer	3.75e-06	4.27e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3R1—hematologic cancer	3.75e-06	4.27e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.73e-06	4.25e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDKN2B—hematologic cancer	3.73e-06	4.24e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ABCB1—hematologic cancer	3.7e-06	4.22e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3R1—hematologic cancer	3.69e-06	4.2e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NCOR1—hematologic cancer	3.67e-06	4.18e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTM1—hematologic cancer	3.67e-06	4.18e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CD86—hematologic cancer	3.66e-06	4.17e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—JAK2—hematologic cancer	3.64e-06	4.15e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ACP5—hematologic cancer	3.63e-06	4.14e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CA9—hematologic cancer	3.63e-06	4.14e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HES1—hematologic cancer	3.61e-06	4.11e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CD86—hematologic cancer	3.6e-06	4.1e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NCOR1—hematologic cancer	3.6e-06	4.1e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTM1—hematologic cancer	3.6e-06	4.1e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NCOR1—hematologic cancer	3.59e-06	4.09e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.59e-06	4.08e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—JAK2—hematologic cancer	3.58e-06	4.08e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HES1—hematologic cancer	3.55e-06	4.05e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CSF2—hematologic cancer	3.55e-06	4.04e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGF1—hematologic cancer	3.55e-06	4.04e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NCOR1—hematologic cancer	3.53e-06	4.02e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FOXO1—hematologic cancer	3.5e-06	3.99e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—IL2—hematologic cancer	3.5e-06	3.98e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGF1—hematologic cancer	3.49e-06	3.98e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CSF2—hematologic cancer	3.49e-06	3.98e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PDGFRB—hematologic cancer	3.49e-06	3.98e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CB—hematologic cancer	3.46e-06	3.94e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FOXO1—hematologic cancer	3.44e-06	3.92e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—IL2—hematologic cancer	3.44e-06	3.92e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PDGFRA—hematologic cancer	3.44e-06	3.92e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PDGFRB—hematologic cancer	3.44e-06	3.92e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PRKCG—hematologic cancer	3.43e-06	3.9e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—JAK1—hematologic cancer	3.43e-06	3.9e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—IDH1—hematologic cancer	3.42e-06	3.89e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CB—hematologic cancer	3.4e-06	3.88e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	3.38e-06	3.85e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.38e-06	3.85e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.38e-06	3.85e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—TXN—hematologic cancer	3.38e-06	3.85e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—JAK1—hematologic cancer	3.37e-06	3.84e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	3.37e-06	3.84e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.31e-06	3.77e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—MTHFR—hematologic cancer	3.24e-06	3.7e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL2RA—hematologic cancer	3.2e-06	3.65e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—MTHFR—hematologic cancer	3.18e-06	3.62e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL2—hematologic cancer	3.18e-06	3.62e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.18e-06	3.62e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TERT—hematologic cancer	3.16e-06	3.61e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	3.15e-06	3.59e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL2—hematologic cancer	3.13e-06	3.56e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TERT—hematologic cancer	3.11e-06	3.55e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.09e-06	3.52e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.09e-06	3.52e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PDGFB—hematologic cancer	3.09e-06	3.52e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	3.04e-06	3.46e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TSC2—hematologic cancer	3.02e-06	3.44e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.01e-06	3.43e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TSC2—hematologic cancer	2.97e-06	3.38e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NUP98—hematologic cancer	2.92e-06	3.32e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGFR3—hematologic cancer	2.9e-06	3.31e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK14—hematologic cancer	2.88e-06	3.28e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	2.86e-06	3.26e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.83e-06	3.22e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.83e-06	3.22e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	2.83e-06	3.22e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ESR1—hematologic cancer	2.82e-06	3.21e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NUP214—hematologic cancer	2.81e-06	3.2e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FN1—hematologic cancer	2.79e-06	3.17e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ESR1—hematologic cancer	2.78e-06	3.16e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.75e-06	3.14e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MTR—hematologic cancer	2.75e-06	3.14e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—BAD—hematologic cancer	2.75e-06	3.14e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NFKBIA—hematologic cancer	2.75e-06	3.14e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FN1—hematologic cancer	2.74e-06	3.12e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NOTCH1—hematologic cancer	2.73e-06	3.11e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CG—hematologic cancer	2.73e-06	3.1e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—BAD—hematologic cancer	2.71e-06	3.09e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	2.71e-06	3.09e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ENO2—hematologic cancer	2.7e-06	3.08e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	2.68e-06	3.06e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CD80—hematologic cancer	2.67e-06	3.04e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CG—hematologic cancer	2.67e-06	3.04e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CG—hematologic cancer	2.67e-06	3.04e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KIT—hematologic cancer	2.67e-06	3.04e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—NRAS—hematologic cancer	2.67e-06	3.04e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CD80—hematologic cancer	2.63e-06	2.99e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	2.62e-06	2.99e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KIT—hematologic cancer	2.62e-06	2.99e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	2.62e-06	2.99e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTPN11—hematologic cancer	2.62e-06	2.98e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.62e-06	2.98e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	2.58e-06	2.94e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SDC1—hematologic cancer	2.56e-06	2.92e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—MAPK3—hematologic cancer	2.55e-06	2.91e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CREB1—hematologic cancer	2.54e-06	2.89e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.53e-06	2.88e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	2.51e-06	2.86e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—BRAF—hematologic cancer	2.51e-06	2.85e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CREB1—hematologic cancer	2.5e-06	2.84e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCL2—hematologic cancer	2.48e-06	2.83e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6R—hematologic cancer	2.48e-06	2.82e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CREBBP—hematologic cancer	2.48e-06	2.82e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CREBBP—hematologic cancer	2.47e-06	2.82e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—BRAF—hematologic cancer	2.47e-06	2.81e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCL2—hematologic cancer	2.44e-06	2.78e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6R—hematologic cancer	2.44e-06	2.78e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	2.43e-06	2.77e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.4e-06	2.73e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ALB—hematologic cancer	2.37e-06	2.69e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAP2K1—hematologic cancer	2.36e-06	2.69e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CD—hematologic cancer	2.35e-06	2.67e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CD—hematologic cancer	2.34e-06	2.67e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.32e-06	2.64e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	2.32e-06	2.64e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ALB—hematologic cancer	2.32e-06	2.64e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	2.31e-06	2.63e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—KRAS—hematologic cancer	2.29e-06	2.61e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	2.28e-06	2.6e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.26e-06	2.58e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	2.26e-06	2.57e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGF2—hematologic cancer	2.24e-06	2.56e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3R1—hematologic cancer	2.22e-06	2.52e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3R1—hematologic cancer	2.21e-06	2.52e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGF2—hematologic cancer	2.21e-06	2.52e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	2.18e-06	2.48e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NQO1—hematologic cancer	2.18e-06	2.48e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CD44—hematologic cancer	2.18e-06	2.48e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—JAK2—hematologic cancer	2.15e-06	2.45e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—JAK2—hematologic cancer	2.12e-06	2.41e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	2.11e-06	2.4e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MDM2—hematologic cancer	2.1e-06	2.39e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.09e-06	2.38e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	2.07e-06	2.36e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MDM2—hematologic cancer	2.07e-06	2.35e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYCS—hematologic cancer	2.06e-06	2.35e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.05e-06	2.33e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CB—hematologic cancer	2.05e-06	2.33e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MTOR—hematologic cancer	2.04e-06	2.33e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	2.04e-06	2.33e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MTOR—hematologic cancer	2.01e-06	2.29e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	2.01e-06	2.29e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HRAS—hematologic cancer	1.95e-06	2.22e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	1.92e-06	2.19e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	1.92e-06	2.18e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	1.9e-06	2.16e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	1.89e-06	2.15e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CASP3—hematologic cancer	1.88e-06	2.14e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL2—hematologic cancer	1.88e-06	2.14e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL6—hematologic cancer	1.87e-06	2.13e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	1.87e-06	2.13e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CASP3—hematologic cancer	1.85e-06	2.11e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL2—hematologic cancer	1.85e-06	2.1e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL6—hematologic cancer	1.84e-06	2.09e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCND1—hematologic cancer	1.83e-06	2.08e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—JUN—hematologic cancer	1.83e-06	2.08e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.82e-06	2.07e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTEN—hematologic cancer	1.8e-06	2.06e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCND1—hematologic cancer	1.8e-06	2.05e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—JUN—hematologic cancer	1.8e-06	2.05e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	1.77e-06	2.02e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTEN—hematologic cancer	1.77e-06	2.01e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTEN—hematologic cancer	1.77e-06	2.01e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	1.74e-06	1.98e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTEN—hematologic cancer	1.74e-06	1.98e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	1.73e-06	1.97e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	1.72e-06	1.96e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—EP300—hematologic cancer	1.72e-06	1.96e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.72e-06	1.96e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	1.7e-06	1.94e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	1.69e-06	1.93e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—EP300—hematologic cancer	1.69e-06	1.92e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EP300—hematologic cancer	1.68e-06	1.92e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.67e-06	1.9e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.67e-06	1.9e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EP300—hematologic cancer	1.66e-06	1.89e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SRC—hematologic cancer	1.64e-06	1.87e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SRC—hematologic cancer	1.61e-06	1.84e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	1.59e-06	1.82e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—STAT3—hematologic cancer	1.58e-06	1.8e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NRAS—hematologic cancer	1.58e-06	1.79e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	1.57e-06	1.79e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	1.55e-06	1.77e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	1.55e-06	1.77e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	1.51e-06	1.72e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	1.48e-06	1.69e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.47e-06	1.68e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MYC—hematologic cancer	1.47e-06	1.67e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	1.46e-06	1.67e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MYC—hematologic cancer	1.44e-06	1.64e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	1.44e-06	1.64e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KRAS—hematologic cancer	1.36e-06	1.54e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	1.33e-06	1.52e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.27e-06	1.45e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.25e-06	1.42e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	1.25e-06	1.42e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.24e-06	1.41e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	1.23e-06	1.4e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TP53—hematologic cancer	1.2e-06	1.37e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TP53—hematologic cancer	1.19e-06	1.35e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HRAS—hematologic cancer	1.15e-06	1.31e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.15e-06	1.31e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	1.13e-06	1.29e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6—hematologic cancer	1.1e-06	1.26e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.09e-06	1.24e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6—hematologic cancer	1.09e-06	1.24e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALB—hematologic cancer	1.07e-06	1.22e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AKT1—hematologic cancer	1.04e-06	1.18e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.03e-06	1.17e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AKT1—hematologic cancer	1.02e-06	1.16e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKT1—hematologic cancer	1.02e-06	1.16e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	1e-06	1.14e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.49e-07	1.08e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTEN—hematologic cancer	8.2e-07	9.34e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—EP300—hematologic cancer	7.82e-07	8.91e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.79e-07	6.59e-06	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AKT1—hematologic cancer	4.73e-07	5.38e-06	CbGpPWpGaD
